デフォルト表紙
市場調査レポート
商品コード
1409326

放出制御型ドラッグデリバリーの世界市場レポート 2024年

Controlled Release Drug Delivery Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
放出制御型ドラッグデリバリーの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

放出制御型ドラッグデリバリーの市場規模は近年急速に拡大しています。2023年の592億米ドルから2024年には661億8,000万米ドルへと、CAGR11.8%で拡大します。歴史的な期間に見られた拡大は、先駆的なドラッグデリバリーシステムのイントロダクション、初期のポリマーベースの製剤の開発、マイクロカプセル化技術の登場、経皮デリバリー法の出現、規制当局の承認や標準化プロセスの進歩など、いくつかの要因に起因しています。これらの要素が総合的に、この時期の放出制御型ドラッグデリバリーシステムの成長と進化に貢献しました。

2023年の放出制御型ドラッグデリバリー市場で最大の地域は北米でした。放出制御型ドラッグデリバリー市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 放出制御型ドラッグデリバリー市場の特徴

第3章 放出制御型ドラッグデリバリー市場の動向と戦略

第4章 放出制御型ドラッグデリバリー市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の放出制御型ドラッグデリバリー市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 放出制御型ドラッグデリバリー市場セグメンテーション

  • 世界の放出制御型ドラッグデリバリー市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ウルスターテクニック
  • コアセルベーション
  • マイクロカプセル化
  • インプラント
  • 経皮
  • 標的デリバリー
  • その他の技術
  • 世界の放出制御型ドラッグデリバリー市場、放出メカニズム別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ポリマーベースのシステム
  • マイクロリザーバーパーティション制御ドラッグデリバリーシステム
  • フィードバック規制されたドラッグデリバリーシステム
  • 活性化調節ドラッグデリバリーシステム
  • 化学的活性化
  • 世界の放出制御型ドラッグデリバリー市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 定量吸入器
  • 注射
  • 経皮パッチおよび眼パッチ
  • その他の用途
  • 世界の放出制御型ドラッグデリバリー市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • クリニック
  • パーソナル
  • 研究
  • その他のエンドユーザー

第7章 放出制御型ドラッグデリバリー市場の地域および国分析

  • 世界の放出制御型ドラッグデリバリー市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の放出制御型ドラッグデリバリー市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の放出制御型ドラッグデリバリー市場

第9章 中国の放出制御型ドラッグデリバリー市場

第10章 インドの放出制御型ドラッグデリバリー市場

第11章 日本の放出制御型ドラッグデリバリー市場

第12章 オーストラリアの放出制御型ドラッグデリバリー市場

第13章 インドネシアの放出制御型ドラッグデリバリー市場

第14章 韓国の放出制御型ドラッグデリバリー市場

第15章 西欧の放出制御型ドラッグデリバリー市場

第16章 英国の放出制御型ドラッグデリバリー市場

第17章 ドイツの放出制御型ドラッグデリバリー市場

第18章 フランスの放出制御型ドラッグデリバリー市場

第19章 イタリアの放出制御型ドラッグデリバリー市場

第20章 スペインの放出制御型ドラッグデリバリー市場

第21章 東欧の放出制御型ドラッグデリバリー市場

第22章 ロシアの放出制御型ドラッグデリバリー市場

第23章 北米の放出制御型ドラッグデリバリー市場

第24章 米国の放出制御型ドラッグデリバリー市場

第25章 カナダの放出制御型ドラッグデリバリー市場

第26章 南米放出制御型ドラッグデリバリー市場

第27章 ブラジルの放出制御型ドラッグデリバリー市場

第28章 中東の放出制御型ドラッグデリバリー市場

第29章 アフリカの放出制御型ドラッグデリバリー市場

第30章 放出制御型ドラッグデリバリー市場の競合情勢と企業プロファイル

  • 放出制御型ドラッグデリバリー市場の競合情勢
  • 放出制御型ドラッグデリバリー市場の企業プロファイル
    • Johnson &Johnson Services Inc.
    • Merck &Co. Inc.
    • Alkermes plc
    • Coating Place Inc.
    • Corium International Inc.

第31章 世界の放出制御型ドラッグデリバリー市場の競合ベンチマーキング

第32章 世界の放出制御型ドラッグデリバリー市場競争ダッシュボード

第33章 放出制御型ドラッグデリバリー市場における主要な合併と買収

第34章 放出制御型ドラッグデリバリー市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10864

“Controlled Release Drug Delivery Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on controlled release drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for controlled release drug delivery? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The controlled release drug delivery market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Technology: Wurster Technique; Coacervation; Micro Encapsulation; Implants; Transdermal; Targeted Delivery; Other Technologies
  • 2) By Release Mechanism: Polymer Based Systems; Micro Reservoir Partition Controlled Drug Delivery Systems; Feedback Regulated Drug Delivery Systems; Activation-Modulated Drug Delivery Systems; Chemically Activated;
  • 3) By Application: Metered Dose Inhalers; Injectable; Transdermal and Ocular Patches; Other Applications
  • 4) By End User: Hospitals; Clinics; Personal; Research; Other End Users
  • Companies Mentioned: Johnson & Johnson Services Inc.; Merck & Co. Inc.; Alkermes plc; Coating Place Inc.; Corium International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Controlled release drug delivery involves a dosage form designed to administer a medicine or medication in a specific manner, providing continuous and predictable kinetics for a predetermined duration.

The primary types of technology employed in controlled release drug delivery include the wurster technique, coacervation, microencapsulation, implants, transdermal delivery, targeted delivery, and others. The wurster technique, also known as fluid bed microencapsulation, encapsulates discrete particles in a fluidized bed using differential air flow to create cyclic movement of material. It encompasses various release mechanisms such as polymer-based systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation-modulated drug delivery systems, and chemically activated methods. These technologies find applications in metered dose inhalers, injectables, transdermal and ocular patches, among others. Major end-users include hospitals, clinics, individuals, research institutions, and others.

The controlled release drug delivery market research report is one of a series of new reports from The Business Research Company that provides controlled release drug delivery market statistics, including controlled release drug delivery industry global market size, regional shares, competitors with a controlled release drug delivery market share, detailed controlled release drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the controlled release drug delivery industry. This controlled release drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The controlled release drug delivery market size has grown rapidly in recent years. It will grow from $59.2 billion in 2023 to $66.18 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The expansion observed during the historic period can be attributed to several factors, including the introduction of pioneering drug delivery systems, the development of early polymer-based formulations, the advent of microencapsulation techniques, the emergence of transdermal delivery methods, and advancements in regulatory approvals and standardization processes. These elements collectively contributed to the growth and evolution of controlled release drug delivery systems during that timeframe.

The controlled release drug delivery market size is expected to see rapid growth in the next few years. It will grow to $105.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.2%. The anticipated growth in the forecast period can be attributed to a shift towards personalized medicine, the integration of technology for enhanced patient convenience, the expanding market for biologics and biosimilars, increased market presence in developing regions, and advancements in polymer science. Major trends expected during this period encompass the use of biodegradable and biocompatible materials, advancements in nanotechnology, the emphasis on personalized medicine and targeted therapies, developments in implantable devices, and innovative encapsulation techniques. These factors are poised to shape and influence the trajectory of controlled release drug delivery systems in the upcoming forecast period.

The increasing prevalence of chronic diseases, also termed noncommunicable diseases (NCDs), is projected to act as a significant driver for the expansion of the controlled release drug delivery market. Chronic diseases, which encompass ailments such as heart disease, cancer, and diabetes, persist over extended periods, necessitating ongoing medical attention and often restricting daily activities. Controlled-release drug delivery plays a pivotal role in treating such chronic conditions. Particularly for patients requiring prolonged treatment or residing in areas with limited healthcare access, drug delivery formulations facilitating extended medication release are paramount. For instance, a September 2022 report shared by the World Health Organization (WHO) highlighted that annually, 41 million people succumb to chronic diseases, accounting for 74 percent of global fatalities. Approximately 17 million individuals lose their lives to chronic ailments before reaching the age of 70. Moreover, 77 percent of deaths attributed to chronic diseases occur in low- and middle-income countries, with anticipated future increases. Thus, the escalating prevalence of chronic diseases fuels the growth of the controlled release drug delivery market.

The upward trajectory in healthcare expenditure is anticipated to drive the expansion of the controlled release drug delivery market in the forthcoming years. Healthcare expenditure encompasses the aggregate financial resources, both public and private, allocated to the healthcare sector within a specified geographic region, country, or economy over a designated timeframe. Within healthcare spending, investments in controlled release drug delivery constitute a multidimensional outlay covering a medicinal product's entire lifecycle, from initial research to post-market surveillance, aiming to enhance treatment outcomes, patient adherence, and overall healthcare efficacy. For instance, as of September 2022, data from the Centers for Medicare & Medicaid Services revealed a 2.7 percent increase in national health spending, amounting to $4.3 trillion in 2021, equating to $12,914 per person and accounting for 18.3% of the GDP. This escalating healthcare spending significantly contributes to the growth of the controlled release drug delivery market.

Technological progression stands out as a pivotal trend gaining traction within the controlled-release drug delivery market. Major enterprises operating in this sector are embracing novel technologies to fortify their market positions. For example, in March 2022, Evonik Industries AG, a Germany-based pharmaceutical company, introduced UDRATEC SoluFlow. This innovative microparticle technology is engineered to enhance the solubility of active medicinal constituents in oral medication formulations. Utilizing an emulsion-based processing technique, UDRATEC SoluFlow overcomes solubility barriers unattainable through traditional production methods. This addition to Evonik Health Care's suite of oral drug delivery system solutions complements existing offerings such as oral excipients such as EUDRAGIT functional polymers, ready-to-fill functional capsules such as EUDRACAPTM, and various technologies and services aimed at optimizing medication performance.

Leading entities within the chocolate syrup market are strategically engaging in partnership initiatives, with a focus on broadening applications in the ophthalmic field. Strategic partnerships denote a collaborative process wherein companies leverage each other's strengths and resources to achieve mutual benefits and foster success. For instance, in March 2023, Hovione, a Portugal-based contract drug manufacturing company, unveiled a collaboration with Ripple Therapeutics Inc. to expand the utilization of Ripple's Epidel technology beyond its current ophthalmic applications. This partnership marks a pivotal step in extending the Epidel platform's reach beyond ophthalmology, combining technical synergy, innovative vision, and a harmonious cultural alignment. Hovione's proficiency in regulated, sustained drug administration, coupled with their expertise in chemical synthesis and pharmaceutical manufacturing, forms a robust foundation for this collaboration. Ripple Therapeutics Inc. operates as a Canada-based pharmaceutical firm.

In November 2022, Alcon, a Switzerland-based pharmaceuticals and medical devices company, completed the acquisition of Aerie Pharmaceuticals, Inc. for an undisclosed sum. This strategic acquisition signifies an expansion of Alcon's diverse range of commercial products and development pipeline within the realm of ophthalmic pharmaceuticals. Aerie Pharmaceuticals, Inc., an esteemed US-based company specializing in the manufacture of ophthalmic solutions, further bolsters Alcon's portfolio and advancements in the ophthalmic pharmaceutical sector through this acquisition.

Major companies operating in the controlled release drug delivery market report are Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc. .

North America was the largest region in the controlled release drug delivery market in 2023. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the controlled release drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The controlled release drug delivery market consists of revenues earned by entities by providing services such as mucoadhesive drug delivery, implantable drug delivery, and gastro-retentive drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The controlled release drug delivery market also includes sales of nebulizers, infusion pumps, and other systems used to provide controlled release drug delivery. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Controlled Release Drug Delivery Market Characteristics

3. Controlled Release Drug Delivery Market Trends And Strategies

4. Controlled Release Drug Delivery Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Controlled Release Drug Delivery Market Size and Growth

  • 5.1. Global Controlled Release Drug Delivery Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Controlled Release Drug Delivery Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Controlled Release Drug Delivery Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Controlled Release Drug Delivery Market Segmentation

  • 6.1. Global Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wurster Technique
  • Coacervation
  • Micro Encapsulation
  • Implants
  • Transdermal
  • Targeted Delivery
  • Other Technologies
  • 6.2. Global Controlled Release Drug Delivery Market, Segmentation By Release Mechanism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymer Based Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Feedback Regulated Drug Delivery Systems
  • Activation-Modulated Drug Delivery Systems
  • Chemically Activated
  • 6.3. Global Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metered Dose Inhalers
  • Injectable
  • Transdermal and Ocular Patches
  • Other Applications
  • 6.4. Global Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Peronal
  • Research
  • Other End Users

7. Controlled Release Drug Delivery Market Regional And Country Analysis

  • 7.1. Global Controlled Release Drug Delivery Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Controlled Release Drug Delivery Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Controlled Release Drug Delivery Market

  • 8.1. Asia-Pacific Controlled Release Drug Delivery Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Controlled Release Drug Delivery Market

  • 9.1. China Controlled Release Drug Delivery Market Overview
  • 9.2. China Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Controlled Release Drug Delivery Market

  • 10.1. India Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Controlled Release Drug Delivery Market

  • 11.1. Japan Controlled Release Drug Delivery Market Overview
  • 11.2. Japan Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Controlled Release Drug Delivery Market

  • 12.1. Australia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Controlled Release Drug Delivery Market

  • 13.1. Indonesia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Controlled Release Drug Delivery Market

  • 14.1. South Korea Controlled Release Drug Delivery Market Overview
  • 14.2. South Korea Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Controlled Release Drug Delivery Market

  • 15.1. Western Europe Controlled Release Drug Delivery Market Overview
  • 15.2. Western Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Controlled Release Drug Delivery Market

  • 16.1. UK Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Controlled Release Drug Delivery Market

  • 17.1. Germany Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Controlled Release Drug Delivery Market

  • 18.1. France Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Controlled Release Drug Delivery Market

  • 19.1. Italy Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Controlled Release Drug Delivery Market

  • 20.1. Spain Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Controlled Release Drug Delivery Market

  • 21.1. Eastern Europe Controlled Release Drug Delivery Market Overview
  • 21.2. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Controlled Release Drug Delivery Market

  • 22.1. Russia Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Controlled Release Drug Delivery Market

  • 23.1. North America Controlled Release Drug Delivery Market Overview
  • 23.2. North America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Controlled Release Drug Delivery Market

  • 24.1. USA Controlled Release Drug Delivery Market Overview
  • 24.2. USA Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Controlled Release Drug Delivery Market

  • 25.1. Canada Controlled Release Drug Delivery Market Overview
  • 25.2. Canada Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Controlled Release Drug Delivery Market

  • 26.1. South America Controlled Release Drug Delivery Market Overview
  • 26.2. South America Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Controlled Release Drug Delivery Market

  • 27.1. Brazil Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Controlled Release Drug Delivery Market

  • 28.1. Middle East Controlled Release Drug Delivery Market Overview
  • 28.2. Middle East Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Controlled Release Drug Delivery Market

  • 29.1. Africa Controlled Release Drug Delivery Market Overview
  • 29.2. Africa Controlled Release Drug Delivery Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Controlled Release Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Controlled Release Drug Delivery Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Controlled Release Drug Delivery Market Competitive Landscape And Company Profiles

  • 30.1. Controlled Release Drug Delivery Market Competitive Landscape
  • 30.2. Controlled Release Drug Delivery Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Alkermes plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Coating Place Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Corium International Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Controlled Release Drug Delivery Market Competitive Benchmarking

32. Global Controlled Release Drug Delivery Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Controlled Release Drug Delivery Market

34. Controlled Release Drug Delivery Market Future Outlook and Potential Analysis

  • 34.1 Controlled Release Drug Delivery Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Controlled Release Drug Delivery Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Controlled Release Drug Delivery Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer